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Executive Summary
Opportunity
Across the globe, hundreds of millions of people suffer from insomnia, which can be
characterized by three attributes: trouble falling asleep, trouble staying asleep, or trouble waking
up. These people are massively affected by the problems they have, disrupting their mood,
productivity, and even their happiness. Insomniacs also typically consume a significantly lower
amount of 7 key vitamins and minerals - B6, B12, C, D, E, Magnesium, and Gammaaminobutyric acid (GABA) - in comparison to those who sleep normally1,3,4,5,6,8,9,10. There are
hundreds of readily available solutions on the market, yet over 85% of people suffering don’t
utilize any solution whatsoever, primarily due to a lack of information about how these solutions
work. While solutions range from supplements like melatonin, which artificially meets a need in
the body, to high-tech beds and pillows, no solution exists for those who want to naturally
address their key deficiencies which contribute to their insomnia.
Company Overview
Insomnovation is a sleep company focused on providing information and access to sleep
solutions for insomniacs and others suffering from sleep problems across the United States. The
Sleep Box, our flagship product, provides an all-encompassing biomedical test for the 7 key
vitamin deficiencies that are correlated with insomnia as well as a monthly subscription box to
provide the vitamins to address those very deficiencies. Users will utilize the resources found on
our website to learn about all solutions available, even those not in their local markets, and
become familiar with the opportunities they have to fix their sleep. We will create a community
of informed sleepers and continue to grow our company so we can work towards putting the
sleep epidemic to rest.
Product and Competitive Advantage
Insomnovation is partnering with UAMS to create the first all-encompassing biomedical
test to scientifically identify customers' vitamin deficiencies that are linked to their insomnia.
Alongside this partnership and test, Insomnovation will provide a simple subscription box that
provides them both a methodology to scientifically identify their deficiencies, as well as the
vitamins to address those deficiencies.
Market Analysis, Customers, and Go-To-Market Strategy
Our findings show that approximately 70 million Americans have chronic sleep issues11,
of which 9 million spend an average of $55 a month on sleep supplements. This leaves 61
million Americans either not satisfied with current products or with a lack of information on how
to solve their problems. Furthermore, 55% of individuals surveyed on our prototype have shown
interest in purchasing the product, leading us to conclude that 33.55 million Americans would be
willing to use our product. As America increases its focus on health and wellness, the investment
received by sleep-tech startups is projected to double in 2022. In 2020 $488M was invested in
sleep-focused startups versus $800M in 202113. Expenditure on sleep products has also increased
5.1% in the past 5 years, equivalent to $18.6 billion.
Currently, we are working to add additional content to our website to further build a
reputation for our business. As we must wait for the comprehensive blood test to be completed,
we will partner with EverlyWell14, a popular blood testing company with hundreds of available
tests on the market, to provide temporary tests for subsets of vitamins (i.e., one for vitamins C,
D, and E). Alongside these tests, we expect to be purchasing the first batch of vitamins in April
to create the first iteration of The Sleep Box to sell to our established user base in July.
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Management Team
Julia Davis, the CEO, has created multiple startups and is an experienced innovator with
multiple current patents pending. Nik Limperis, CFO, has 5 years of sales experience and is a
current CFA level 1 candidate. Josh Shackleton, CTO, has over 8 years of web development
experience and has created multiple professional websites. Wesley Smith, COO, has 3 years of
experience both in sales and professional networking. Finally, Masako Suzuki, CMO, is a recent
graduate of the U of A with a BS in Marketing, with over 3 years of related experience, and is
the current e-Commerce Brand Growth Manager at CoreTrex LLC.
Capital Needed & Financial Strategy
We are initially seeking an angel investment of $150,000 to build partnerships with
Packlane, a custom packaging manufacturer for the physical box, marketing our product, and
beginning research and development. Within the next 2 months, we will submit a project
proposal to the National Science Foundation (NSF), immediately followed by a 6-month phase
of writing our proposal for a SBIR grant. Phase 1 of SBIR funding is for 12-month long proofof-concept trials, and we will be awarded $250,000 for this purpose, which will allow us to
conduct initial prototyping of the blood test. Phase 2 will award $750,000 over the course of the
following 2 years for finalizing development and meeting regulatory requirements for our blood
test. Insomnovation aims to have an approximate market valuation at $44.3 million by 2026,
with a goal of being acquired by a large-scale vitamin or wellness company such as Nestle
through their Garden of Life supplement line or Pharmavite, an Otsuka Pharmaceuticals
subsidiary which produces the Nature Made vitamin line.
Problem and Opportunity
Every night, over 70 million Americans struggle with chronic sleep issues11, and over
33% of Americans report having trouble sleeping. Among these struggling Americans, the
leading sleep disorder is insomnia – difficulty falling asleep, staying asleep, or waking up15.
Most people who struggle with insomnia turn to sleep aids such as melatonin or Ambien16,
products designed to either artificially subdue a deficiency in the body or sedate the brain to
sleep. However, a large percentage of these people stop using these supplements due to negative
side-effects after using them such as nausea and dizziness, which may contribute to an increased
difficult of sleep17,18, or the loss of efficacy after a prolonged period. Melatonin, the most
common supplement for sleep issues, has a problem: it’s non-standardized, which means that
each pill can differ in size from each other pill even in the same container18. This means people
cannot be sure that they are getting the amount they need to have a good sleep guaranteed each
night. Products such as these on the market today attempt to cover up sleep problems instead of
getting to the root of someone’s sleep issues.
Some companies do provide vitamin treatments instead of supplements. For those
companies, such as Care/Of20 or Proper21, there is a focus on holistic wellness through an
extremely large and diverse inventory of vitamins and minerals, rather than a specific focus on
sleep with diagnostic testing and a specialized inventory of the core vitamins whose deficiencies
contribute to insomnia. No centralized sleep solution exists for those searching for a true remedy
for their sleep issues.
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Solution
The Sleep Box by Insomnovation is
one of the first sleep subscription boxes in the
market focused on treating deficiencies in the
7 key vitamins and minerals that are linked to
insomnia1,3,4,5,6,8,9,10. We will use our blood
test to scientifically identify each customers’
core deficiencies and provide the solutions
through a monthly subscription box that holds
the exact vitamins in the dosages they require.
As part of our retention plan, customers will
be given a new diagnostic test every six
months to reevaluate their deficiencies and
ensure our solution is properly addressing
them. Premium add-ons such as Gammaaminobutyric Acid (GABA) chocolate, a Japanese sleep remedy, and caffeine sensitivity tests
will be included to add a sense of surprise and excitement in each box so customers will be more
inclined to rely on us to get them the sleep they need.
Those premium add-ons, which include regional solutions like valerian root, are intended
to further entice customers to utilize our box rather than just our blood test. With the intention of
providing new, unique solutions from around the world, we could create more confusion by
adding more options for our customers, further oversaturating the market. To avoid this, we are
creating articles on our website to better inform consumers of the benefits of each product, and
plan to host a bi-weekly podcast where we interview sleep experts on various sleep-related
topics, with Q&A. We will utilize our patented blood test, superior products, and information
provided on our website to become the center of assistance for those suffering from insomnia.
Validation of Business Idea and Venture
Target Market Refinement
Originally, we aimed to target women 18 through 45 with our product. With further
testing using advertisements, messaging, and our website, we found that over 70% of the 6,000
website users were females 55+. They were much more receptive to our messaging, with an
average cost-per-click of our ad being near 8 cents, compared to the nearly 20 cents for all other
age groups.
Originally, while these women came to our website often, the bounce rate on our site was
peaking over 90%. By adding informative content in the form of blog posts and better
information on our products, our bounce rate dropped to 65% in 4 days. Thus, we identified our
customers as primarily females aged 55+ and changed our primary focus from attempting to sell
our products to create an information base which we will use to sell products in the future. We
plan on continuing refining our brand image and marketing to better reach our target market,
using data from Facebook Pixel and Google Analytics to statistically evaluate our attempts, and
reach a statistically significant sample size of 10,000 users before the end of April.
Validation of Pricing Strategy and Content
We conducted over 50 customer discovery interviews, alongside multiple concept,
prototype, and pricing surveys to find the right price, product, and market fit. We found that 62%
of customers were willing to spend $50 per month on a monthly recurring subscription box, with
that increasing to 75% if the box only contained vitamins (in lieu of supplements such as
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melatonin). 70% of customers prefer a blood test to a survey because surveys do not get to their
personal issues, instead generalizing their issues into a “one-size-fits-all” package not guaranteed
to help them. Purchase interest for our product increased further by 15% when our product
contained a blood test.

Despite having such a large percentage of survey respondents likely purchasing our
product, there were trends in those who weren’t interested. Many of those reports that their
problems stem from a lack of information or trust in our vitamin solution. Because of this, we
understood our primary focus would be to both scientifically research our vitamin solution and
provide educational opportunities for our solutions so users would have a reason and a way to
understand our solutions. In doing so, we can further broaden our reach on the market and help
more people get their best sleep.
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Market Overview and Analysis
Market Summary
The sleep market within the United States sees an expenditure of $79 billion annually on
sleep solutions, with $6 billion dedicated towards sleep issue diagnosis and supplements (SDS).
Globally, people spend $439 billion on any sleep-related problems, with $33 billion of that
specifically for SDS, 7.5% of the
market. Initially, we will target the US
market, which is 18% of the global
market, or $79 billion, and applying the
same 7.5% globally spent on SDS we
have found that the US market size for
SDS is $5.94 billion.
Taking the 9 million individuals
in America who currently spend money
on sleep diagnosis and supplementation
and the current market, we have found
the average monthly amount spent on
sleep solutions to be $55 per month or $660 per year. When applying this to the 61 million
Americans not currently spending money on sleep solutions but reporting having problems
sleeping, we reach a total addressable market of $40.2 billion yearly.
Competitive Analysis
Primarily, Insomnovation has two direct competitors: Care/Of and Proper. Both
companies ship their products to your door, but they differ greatly in their contents. Care/Of
specifically ships personalized vitamins to your door using a comprehensive survey to identify
what problems one may have but doesn’t focus on sleep and aims to address all health issues
generally. Proper, on the other hand, uses supplements such as Ashwagandha and Kava and ships
the products to your door, but doesn’t directly address the issues that lead to insomnia directly;
instead, they attempt to ease the symptoms. Insomnovation, in comparison, uses the biomedical
test to diagnose vitamin deficiencies, with a primary focus on sleep so that customers receive the
best treatment to help treat insomnia while providing an all-natural solution shipped right to your
door.
Intellectual Property
Insomnovation will create a patented blood test through a partnership with the key
biomedical scientists and researchers at UAMS. We plan on partnering with Elisabet Børsheim,
Ph.D, a professor in the pediatric department at UAMS. She has research in pediatric nutrition
with specific focus on suboptimal nutrition in metabolic disorders. While the University requires
all research under it be owned by the university and licensed out, we are working on a deal in
which we are the only authorized body to use this test. We plan to partner with an experienced
phlebotomist in the future to lead our research. Our blood test will be akin to other tests such as
the Lets Get Checked Essential Vitamin Test, an at-home finger prick test that can detect precise
levels of a small group of vitamins.
For filing our patent, we will hire Meredith Lowry at Wright Lindsay Jennings LLP, an
experienced patent attorney with hundreds of successful patent filings. We plan on filing our
provisional patent in 4 to 6 months, once we can concretely define the complexities of our test.
Once the provisional patent is filed, we will have 12 months to apply for a US Utility Patent,
alongside patents in other countries through the Patent Cooperation Treaty, which takes around
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18 months to be reviewed and accepted. In all, we are looking at around 3 years from original
provisional patent filing to our patented blood test.
Go-To-Market Strategy
We have begun by creating advertisements to our website, which will have both our
products and informational articles about the solutions we provide. With our market identified as
primarily women 55+, we have begun using Facebook groups, such as one for mothers of U of A
students, to begin spreading the word to our potential early adopters. We have also already
started establishing thought leadership through developing a sleep podcast, where verified sleep
experts will join us to talk and answer questions about sleep issues. After establishing this
trusting base, we will begin refining the marketing of our product for people of all ages while
continuing to provide information for our customers, so they will know Insomnovation is where
they will come to get answers for their sleep questions.
The US Sleep market contributes 18% of the global expenditure on sleep solutions, the
highest of any individual country. On average, Americans spend $55 per month on sleep
solutions. To better refine our insight into the price of our product, we surveyed over 500 people,
and found that a majority of respondents, 65%, were willing to spend $55 per month on sleep
solutions. At this price per box, we retain a 65% profit margin, which allows us to focus on
research and development for new tools, as well as marketing for existing solutions.
Through our participation in the EMPOWER Accelerator, we have made contacts with
those in assisted living care centers, the population of which often are affected by the very issues
we aim to address. The customer acquisition cost for this method would be virtually nothing, as
we can easily utilize connections between these centers to reach more customers. Because of
this, we are planning on targeting these centers as another stage of early adopters for our box.
This provides an opportunity to further develop and refine the contents of our box to better reach
our target market.
Operating Strategies
Research and Development
Insomnovation’s R&D team consists of Ms. Rinalda Proko, and scientists at the
University of Arkansas for Medical Sciences (UAMS) to develop the desired blood test for all 7
key vitamins related to insomnia, with the additional ability to determine the exact level of each
vitamin in the body. We are working specifically with Ms. Proko to write a three-page project
proposal to the NSF, a prerequisite for obtaining SBIR funding. We plan on completing the
development of the blood test in the next 36 months, which we will fund by an angel investment
from Startup Junkie, the Safe Agreement through the Arkansas I-Fund, and an SBIR grant. After
completing the blood test, we will undergo clinical trials to prove the efficacy and accuracy of
the test, after which we will seek FDA authorization to officially use our blood test. We also will
begin filing our provisional patent for our blood test in the coming months to prepare for the later
stages of development.
Current Stage of Development
Currently, we are in the midst of forming partnerships to take our R&D to the next level,
into direct development and clinical trials. Until that is completed, we will utilize a partnership
with EverlyWell, a popular blood-testing company with a massive inventory of blood tests. By
initially using a survey to narrow down their deficiencies, we can still use already-made blood
tests for subsets of vitamins (such as a test for vitamins B12, C, and D) to further confirm or
deny their key inadequacies and provide a unique value to the product before the comprehensive
test is finished.
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We have recently been accepted into
the EMPOWER Accelerator, powered by
Startup Junkie and the Science Venture Studio.
This provides us with five industry mentors,
with experience in industry,
commercialization, and technology. These
mentors have already begun to assist us in
reaching our early adopters and preparing our
proposals for funding.
Regulatory Strategy
As vitamins are not regulated by the
FDA, we do not need to worry about
regulation for those. However, we will require
FDA approval on the blood test, and other
regulatory approvals such as HIPAA for taking people’s blood, privacy disclosure, and cyber
security for storing customers’ private information. We will partner with Wright Lindsey &
Jennings LLP law firm and one of their privacy attorneys who specialize in HIPPA. Once we
navigate through the legal seas and achieve HIPPA compliance, we can begin selling our full
product.
Marketing Plan
Given that a major proportion of the population who have sleep problems don’t use sleep
solutions, our primary focus is providing education on how vitamin deficiencies are connected to
poor sleep quality. By creating a podcast and informational articles on our website, we will better
educate our customer base about the solutions they are missing out on and provide them with
opportunities to try those same solutions.
We have utilized the three-tiered marketing strategy based on Dr. Clayton Alderfer’s
Existence, Relationship, Growth (ERG) Theory. The first tier, function marketing, is about
describing to users how your product solves a need or fits a niche in the market; we provide the
first blood test for key vitamins linked to sleep, a focus on a natural solution, and provides an
information base for the various sleep solutions. Next, relationship marketing, or how we explain
what customers should feel when using our product. By providing scientific methods of
addressing their sleep, they should feel secure in their ability to get the rest they need, and feel
comfortable not relying on artificial, addicting products. Finally, the third tier, or innovation
marketing, where the user is explained how the product distinguishes itself from its competition.
Our sleek, modern design represents the simple desire of getting good sleep, and our simple
focus on getting you there. Once patented, we will also strongly advertise our blood test as a key
factor in securing good sleep each night.
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Risk Management
Insomnovation faces many challenges to become successful in the saturated sleep market,
and we must face these challenges head-on to overcome any barriers preventing our success.
Name of Risk

Explanation

Risk Level

Impact Level

Product Efficacy

Efficacy of Vitamin solution

High

High

Customer Retention Subscription length

High

High

Accuracy of Test

Margin of error / strength of blood test

High

High

Competition

Other sleep solutions

Medium

High

Vitamin Dosage

Overdosing / correct dosages

Medium

Medium

Product Efficacy
Vitamins are a popular yet unproven solution to many medical issues. Despite seeming
like obvious answers, research in this area is limited. Fundamentally, vitamins are not regulated
by the FDA, which means that while we don’t face any regulatory issues in getting our product
to market, we will eventually have to build credibility and trust about our vitamin solution. We
have begun to do so by implementing thought leadership in the form of our podcast and
informative articles on our website and will further investigate the topic through SBIR-funded
research.
Customer Retention
Our unique value proposition is primarily the biomedical test for the key vitamin
deficiencies linked to insomnia. A customer may see that once getting the test, our other products
become obsolete, especially with the readily available vitamin stock in stores worldwide.
However, customers will be aware of the recurrence of deficiencies through our website and will
be required to purchase a test anyways after a couple of months to re-check their deficiencies. If
a customer is interested in our test, they will be financially motivated to purchase a subscription
over simply a blood test.
Accuracy of Test
By relying on a biomedical test to identify deficiencies in our customers’ bodies, we also
rely on the test to be accurate and consistent for those same customers. Our partnership with
UAMS will add credibility to our test, and further R&D will eliminate any worries one may have
about us.
Competition
With all ventures comes competition. Without addressing other solutions that customers
will compare us to, we cannot gauge our reputation and progress. We uniquely provide the
biomedical test for deficiencies, which allows us and us alone to provide a scientific method of
identifying customers’ issues, unlike that of our competitors.
Vitamin Dosage
Vitamins and their dosages are unregulated by the FDA, which means the only body
keeping vitamin dosages in check would be ourselves. We don’t want to have a customer
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overdose on vitamins, but we want them to have appropriate dosages to address their
deficiencies. We plan on utilizing Good Manufacturing Processes to ensure our vitamins are safe
for our customers.
Management Team & Advisory Board
Management Team
Team Member

Relevant Qualification

Julia Davis
Chief Executive
Officer

● Experience interning with 2 local startups and 2 large
corporations
● Developed product to prevent gasoline spillage at the pump that
is patent pending

Nik Limperis
Chief Financial
Officer

● CFA level 1 candidate
● 3 years experience in economic and financial forecasting
● 5 years sales experience

Josh Shackleton
Chief Technology
Officer

●
●
●
●

Wesley Smith
Chief Operating
Officer

● LLC for clothing company
● 3 years sales and professional networking experience

Masako Suzuki
Chief Marketing
Officer

● BS Business Administration (Marketing) - University of
Arkansas (2021)
● Experience interning with 3 startups in Marketing, PR, Operation,
and Commercialization in medical consultation, e-commerce
consulting, etc.
● Current e-Commerce Brand Growth Manager at CoreTrex LLC

4 years of computer science experience
8 years experience web development
5 years experience object oriented programming
Creator of multiple professional websites

Advisory Board
Advisor

Area of Expertise

Qualifications

Beth
Cobb

● Clinical
Research
● Healthcare
Management
● Medical
Devices

● 3+ years experience with NOWDx currently serving as
COO
● 8 years experience as Business Director with Cincinnati
Children’s Hospital Medical Center

Jennifer
Smith

● Health law
attorney
● HIPAA
Privacy and

● 10+ years of experience as a health law attorney.
● Medical staff bylaws, privileging, and peer review
● Professional contracting and licensing issues; government
investigations and regulatory actions
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Security

● HIPAA Privacy and Security, and the Affordable Care
Act, including the Employer Shared Responsibility
Provisions.
● Extensive experience advising clients on the Healthcare
Quality Improvement Act, Arkansas Peer Review Fairness
Act, Patient Safety and Quality Improvement Act, and
more.

Dr.
Lazarte

● Medical
Doctor
● Health
Entrepreneur

● 6+ years as Founder & Medical Doctor at Basis Health
● Medical Doctor at Rural Physicians group

Dr.
Daya

● Health
Entrepreneur
● Sleep Expert
● Medical
Doctor

● Founder and director of AarogyaSeva: Global Health
Volunteer Alliance
● Assistant Professor of biomedical and computer
engineering at Syracuse University College of
Engineering and Computer Science
● Founder and vice-president of the Madhyama Prasaran
and Scientific Research Foundation

Rinalda
Proko

● Molecular
Biology

● Graduate research assistant at the University of Arkansas
● 3+ years experience as as molecular biologist specialist at
the National Reference Virology Laboratory at the
Institute of Public Health in Tirana, Albania
● Serves as a member of the Committee for Postdocs and
Students (COMPASS) at the American Society for Cell
Biology (ASCB)

Andres
Lazarte

● Venture
Capital
● Investor
● Entrepreneur

● 6 years as head of strategy at Basis Health
● 8 years of experience in entrepreneurial areas including
investor relations, business development, and venture
capital.
● Co-founder and director of business development for
Idahome Solar.

Randy
Allison

● Technology
● Senior Living
● Community
Based
Healthcare

● Nearly three decades in technology and executive sales
● 8 years Owner and Administrator of Interim HealthCare
of San Gabriel Valley
● Home health care and senior living foci
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Financials
Revenue
Our revenue will be through the continued subscription of users. With the cost of
acquiring the materials and delivering this product (the vitamins within, the box created by a
third party, and shipping costs) we expect a total gross margin between 65%, equivalent to $37
per box. Over time, the costs saved from economies of scale and in-house box production will
allow for an increased gross margin of 70%.
We are primarily operating in the United States because 18% of all money spent on sleep
solutions globally originate from the United States. With only the US being targeted and from
our population and spending analysis, this allows for a $46 billion total addressable market.
Eventually, we plan on expanding into other developed markets such as Europe to access a
similar customer base as that of the US, while expansion into underdeveloped markets such as
India provide opportunities to establish ourselves as a name-brand of a rapidly growing middle
class.
Exit Strategy
We plan for an acquisition in the years past 2024, with the desired acquisition price of
$44.3 million at the beginning of 2026. This model is based on EV/Revenue ratios of other
subscription boxes (ex. Barkbox has an EV / Rev ratio of 2.22) and sleep-focused businesses
(Eight Sleep holds a ratio of 3).
The potential acquisition offers come from Otsuka Pharmaceuticals, a Japan-based
company whose holding company owns Pharmavite, the producer of Nature Made vitamins in
the United States. Nestle has also been considered a potential buyer, having previously acquired
the natural vitamin producer Garden of Life in 2017. Both companies post annual net incomes of
hundreds of millions of dollars and billions in sales, meaning that these companies would have
no issue in acquiring Insomnovation at our estimated value. As Garden of Life is already sold
through Whole Foods and lacks specific vitamins dedicated to sleep, this fits two niches that we
provide. Pharmavite also utilizes vitamin selling through Nature Made, though lacks the
additional quality and standardization of vitamin quantities that we can provide.
Financial Notes
1. Sales plan to start in July of 2022, with each month afterward showing a doubling in quantity at
the most optimistic levels. Growth at this level would slow into 2023, but a goal of 0.01% of our
potential market at the conclusion of the year. This growth would continue to slow into 2024,
with a hopeful acquisition of 0.08% of our target market being acquired.
2. Sales for lower growth levels have also been calculated, with levels accounting for 50% growth
and 25% growth in the initial months of sale in 2022. Financial statements below are based off of
the 50% growth model. The rate that these provide is also carried over into the 2023 and 2024
operating years following a trend of slowing sales as seen in the optimistic growth model. These
lower sales would mean a higher initial stability for the business but would slow research and
expansion significantly, especially in the long run. Potential downsides here would be a need to
adjust salary dates for executives and to avoid acquiring assemblers and bookkeepers. In this
situation, most activity and resources would be dedicated to research rather than sales.
3. Cost of goods sold including labor, material, and overhead is expected to be 35% of revenue for
each box in the first year of sales in 2023, or approximately $18 per box. With the eventual
increase in scale, we can reduce the costs of these boxes by $2 per unit through continued
purchase plans in 2024, providing a COGS of 30% of sales in the second year of sales.
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4. Research and development allocation will be restricted by revenue at first, but it will increase
largely due to SBIR Phase I grants. We also expect to allocate 40% of our revenues to the
development of our blood test as well. Research costs may be reduced with patent collaboration
with the University of Arkansas.
5. Marketing is expected to take approximately 13% of revenue for the first five years of business.
2023 will see a marked increase to 25% of revenue to greatly expand our marketing for the
subscription box. Subsequent years will see a return to the baseline of 13% unless otherwise
persuaded by changes in revenues.
6. Insurance costs are expected to be $53 monthly, or approximately $636 annually for 2022 and
2023. We expect to increase this to $2,250 annually in 2024.
7. Patent and legal services are expected to be $28,000 in 2023, with further costs of $42,000 being
incurred in 2024.
8. Salaries for team members will begin in 2023, with the CMO and COO earning $26,000 for their
yearly work. The CFO and CEO will begin receiving salaries in 2024, and a bookkeeper and
assembler will be acquired to keep up with product sales and demand respectively. 2025 will see
an increase to assemblers as necessary, though automated alternatives will be evaluated at this
time. This trend will continue into 2026, where necessity of labor over capital assemblers will
again be considered, and whereupon a second bookkeeper will be acquired. Salaries will grow at
a rate of 5% per year.

9. Payroll taxes will take up an additional 7.65% of salaries as is required by the Federal Insurance
Contributions Act (FICA).
10. Corporate income taxes are expected to be standard with US operations. C-Corp income is taxed
at a federal rate of 21% with a state rate of 6.5%, for an estimated total of 27.5%.
11. Accounts receivable are expected to be 5% of total sales. We estimate that 65% of these will be
receivable within 30 days, 25% will be receivable within 60 days, and the final 10% of
receivables being acquired within 90 days.
12. Inventory will be first acquired 3 months prior to our anticipated sales. We anticipate the first set
of sales to occur in July from the families of the executives and the executives themselves.
13. Long-term assets are not planned on being acquired within the first three years of sales. The
company will remain relatively disjointed for 2022 and 2023 to help reduce costs associated with
acquisition. We will be evaluating asset acquisition pertaining to box assembly within 2024,
when we expect it would be worthwhile to reduce the cost of labor for assemblers.
14. Grant funding is assumed to be gained from successful NSF SBIR Phase I of $250,000 in 2023.
Further funding of $400,000 will be acquired from NSF SBIR Phase II in the first year of 2024.
An initial quantity of $5,000 of personal capital investment from team members is expected in
July to ensure short-term sustainability. Greater, unexpected quantities of cash inflows will be
dedicated towards research spending.
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